Page 16 - GPD-4-2

Gene & Protein in Disease Chinese herbs and stem cells in neurology

trial. Ther Adv Psychopharmacol. 2012;2(4):131-138. 26. Rahimi Darehbagh R, Seyedoshohadaei SA, Ramezani R,
Rezaei N. Stem cell therapies for neurological disorders:
doi: 10.1177/2045125312445894
Current progress, challenges, and future perspectives. Eur J
15. Shu T, Pang M, Rong L, et al. Effects of Salvia miltiorrhiza Med Res. 2024;29(1):386.
on neural differentiation of induced pluripotent stem cells.
J Ethnopharmacol. 2014;153(1):233-241. doi: 10.1186/s40001-024-01987-1
27. Pluchino S, Martino G. The therapeutic use of stem cells
doi: 10.1016/j.jep.2014.02.028
for myelin repair in autoimmune demyelinating disorders.
16. Pao LH, Lu SW, Sun GG, Chiou SH, Ma KH. Three Chinese J Neurol Sci. 2005;233(1-2):117-119.
herbal medicines promote neuroproliferation in vitro, and doi: 10.1016/j.jns.2005.03.026
reverse the effects of chronic mild stress on behavior, the
HPA axis, and proliferation of hippocampal precursor cell 28. Kalladka D, Sinden J, Pollock K, et al. Human neural
in vivo. J Ethnopharmacol. 2012;144(2):261-269. stem cells in patients with chronic ischaemic stroke
(PISCES): A phase 1, first-in-man study. Lancet.
doi: 10.1016/j.jep.2012.09.002 2016;388(10046):787-796.
17. Hoang DM, Pham PT, Bach TQ, et al. Stem cell-based therapy doi: 10.1016/S0140-6736(16)30513-X
for human diseases. Signal Transduct Target Ther. 2022;7(1):272.
29. Alizamir T, Akbari M, Mokhtari T, Hassanzadeh G.
doi: 10.1038/s41392-022-01134-4 Associated functional motor recovery induced by
18. Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical Intracerebroventricular (ICV) microinjection of Wharton’s
applications of stem cell-derived exosomes. Signal Transduct jelly mesenchymal stem cells following brain ischemia/
Target Ther. 2024;9(1):17. reperfusion injury in rat: Decreased dark neurons and Bax
gene expression in the cerebral cortex. J Contemp Med Sci.
doi: 10.1038/s41392-023-01704-0 2017;3(12):319-325.
19. Kolios G, Moodley Y. Introduction to stem cells and 30. Ross CA, Tabrizi SJ. Huntington’s disease: From molecular
regenerative medicine. Respiration. 2013;85(1):3-10. pathogenesis to clinical treatment. Lancet Neurol.
doi: 10.1159/000345615 2011;10(1):83-98.
20. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of doi: 10.1016/S1474-4422(10)70245-3
pluripotent stem cells from adult human fibroblasts by 31. Assinck P, Duncan GJ, Hilton BJ, Plemel JR, Tetzlaff W. Cell
defined factors. Cell. 2007;131(5):861-872. transplantation therapy for spinal cord injury. Nat Neurosci.
doi: 10.1016/j.cell.2007.11.019 2017;20(5):637-647.
21. Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. doi: 10.1038/nn.4541
Stem cells: Past, present, and future. Stem Cell Res Ther. 32. Noori L, Arabzadeh S, Mohamadi Y, et al. Intrathecal
2019;10(1):68. administration of the extracellular vesicles derived from
doi: 10.1186/s13287-019-1165-5 human Wharton’s jelly stem cells inhibit inflammation and
attenuate the activity of inflammasome complexes after
22. Alessandrini M, Preynat-Seauve O, De Bruin K, Pepper MS. spinal cord injury in rats. Neurosci Res. 2021;170:87-98.
Stem cell therapy for neurological disorders. S Afr Med J.
2019;109(8b):70-77. doi: 10.1016/j.neures.2020.07.011

doi: 10.7196/SAMJ.2019.v109i8b.14009 33. Reis C, Akyol O, Ho WM, et al. Phase I and Phase
II therapies for acute ischemic stroke: An update on
23. Yamanaka S. Pluripotent stem cell-based cell therapy- currently studied drugs in clinical research. Biomed Res Int.
promise and challenges. Cell Stem Cell. 2020;27(4):523-531. 2017;2017:4863079.
doi: 10.1016/j.stem.2020.09.014 doi: 10.1155/2017/4863079
24. Blurton-Jones M, Kitazawa M, Martinez-Coria H, et al. 34. Thomsen GM, Gowing G, Svendsen S, Svendsen CN. The
Neural stem cells improve cognition via BDNF in a past, present and future of stem cell clinical trials for ALS.
transgenic model of Alzheimer disease. Proc Natl Acad Sci Exp Neurol. 2014;262(Pt B):127-137.
United States Am. 2009;106(32):13594-13599.
doi: 10.1016/j.expneurol.2014.02.021
doi: 10.1073/pnas.0901402106
35. Zhang Y, Zhang ZG, Chopp M, Meng Y, Zhang L,
25. Parmar M, Grealish S, Henchcliffe C. The future of stem Mahmood A, Xiong Y. Treatment of traumatic brain
cell therapies for Parkinson disease. Nat Rev Neurosci. injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.
2020;21(2):103-115. J Neurosurg. 2017;126(3):782-795.
doi: 10.1038/s41583-019-0257-7 doi: 10.3171/2016.3.JNS152699

Volume 4 Issue 2 (2025) 8 doi: 10.36922/gpd.4835